ScripsAmerica, Inc.

SCRCQ

US8110661092

Drug Retailers

Market Closed - OTC Markets Other stock markets 08:10:00 2023-12-01 pm EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2018	AEM Medical Group LLC cancelled the acquisition of 90% equity interest of PIMD International LLC from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	CI
2018	Jaysukh Sabhaya cancelled its acquisition of Pharmacy Administration, Inc. from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	CI

ScripsAmerica, Inc. Announces Resignation of Anderson Triggs as Director

June 16, 2016 at 11:22 am EDT

ScripsAmerica, Inc. announced that on June 14, 2016, Anderson Triggs formally resigned as a director.

Latest news about ScripsAmerica, Inc.

AEM Medical Group LLC cancelled the acquisition of 90% equity interest of PIMD International LLC from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	18-03-29	CI
Jaysukh Sabhaya cancelled its acquisition of Pharmacy Administration, Inc. from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	18-01-17	CI
Motion for Joint Administration Approved for ScripsAmerica, Inc.	17-09-15	CI
Motion for Joint Administration Filed by ScripsAmerica, Inc.	17-08-28	CI
Affiliate Company Joined ScripsAmerica, Inc. Bankruptcy	17-07-21	CI
Motion for Asset Sale Approved for ScripsAmerica, Inc.	17-03-30	CI
AEM Medical Group LLC entered into asset purchase agreement to acquire 90% equity interest of PIMD International LLC from ScripsAmerica, Inc. (OTCPK:SCRC.Q) $0.03.	17-03-29	CI
Motion for Asset Sale Filed by ScripsAmerica, Inc.	17-03-10	CI
Motion For Case Conversion Approved for ScripsAmerica, Inc.	17-02-08	CI
Motion for Case Conversion Filed by ScripsAmerica, Inc.	17-01-29	CI
Motion for Asset Sale Approved for ScripsAmerica, Inc.	17-01-24	CI
Notice for Asset Purchase Agreement Filed by ScripsAmerica, Inc.	17-01-24	CI
Jaysukh Sabhaya entered into an asset purchase agreement to acquire Pharmacy Administration, Inc. from ScripsAmerica, Inc. (OTCPK:SCRC.Q) for $0.15 million.	17-01-23	CI
Liquidation Plan and Disclosure Statement Filed by ScripsAmerica, Inc.	17-01-15	CI
First Motion for Exclusivity Period Extension Filed by ScripsAmerica, Inc.	17-01-03	CI
First Motion for Exclusivity Period Extension Withdrawn by ScripsAmerica, Inc.	16-11-29	CI
First Motion for Exclusivity Period Extension Filed by ScripsAmerica, Inc.	16-11-14	CI
Bidding Procedure Approved for ScripsAmerica, Inc.	16-11-03	CI
Motion for Asset Sale Filed by ScripsAmerica, Inc.	16-10-14	CI
ScripsAmerica, Inc. will Change its Ticker to SCRC.Q from SCRC	16-09-09	CI
ScripsAmerica, Inc. Filed for Bankruptcy	16-09-07	CI
ScripsAmerica, Inc. Announces Board Changes	16-07-20	CI
ScripsAmerica, Inc. Announces Resignation of Anderson Triggs as Director	16-06-16	CI
ScripsAmerica, Inc. Reports Earnings Results for the Fiscal 2014	16-02-01	CI
ScripsAmerica Mulls Acquisitions	15-08-18	CI

ScripsAmerica, Inc. is engaged in the distribution of prescription and over the counter pharmaceuticals. The Company's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). It also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.

Sector

Drug Retailers

More about the company

Sector Other Drug Retailers

	1st Jan change	Capi.
SCRIPSAMERICA, INC.	-.--%	141
WALGREENS BOOTS ALLIANCE, INC.	-32.21%	15.27B
JD HEALTH INTERNATIONAL INC.	-31.97%	10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-30.42%	6.06B
YIFENG PHARMACY CHAIN CO., LTD.	+8.14%	6.04B
MATSUKIYOCOCOKARA & CO.	-11.41%	5.86B
NAHDI MEDICAL COMPANY	-1.17%	4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+52.19%	4.29B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-14.86%	3.33B
WELCIA HOLDINGS CO., LTD.	-6.93%	3.01B

Other Drug Retailers